IIdeeea Therapeutics — Seed · €2.3M
Advanced-therapy biotech Ideeea Therapeutics closed a €2.3M seed round backed by private investors and CDTI under the PERTE for Cutting-Edge Health. Funds accelerate AGAcell, a preclinical allogeneic mesenchymal stem-cell programme for androgenetic alopecia.
Lead not disclosed
RoundSeed
Announced3 Jun 2025
CityMadrid · reported Alcobendas
SectorHealthtech & Bio · Biotech
Source
D
D
